APA (7th ed.) Citation

O, Z., S, N., A, O., M, C., M, L., I, M., . . . T, W. (2026). A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.CCR-26-0874

Chicago Style (17th ed.) Citation

O, Zamulko, et al. "A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in Patients with Metastatic Head and Neck Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 2026. https://doi.org/10.1158/1078-0432.CCR-26-0874.

MLA (9th ed.) Citation

O, Zamulko, et al. "A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in Patients with Metastatic Head and Neck Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 2026, https://doi.org/10.1158/1078-0432.CCR-26-0874.